1. Home
  2. XBP vs TVGN Comparison

XBP vs TVGN Comparison

Compare XBP & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBP Europe Holdings Inc.

XBP

XBP Europe Holdings Inc.

HOLD

Current Price

$2.93

Market Cap

24.4M

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$3.89

Market Cap

21.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBP
TVGN
Founded
N/A
2020
Country
United States
United States
Employees
10200
18
Industry
Business Services
Blank Checks
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
24.4M
21.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XBP
TVGN
Price
$2.93
$3.89
Analyst Decision
Buy
Hold
Analyst Count
1
1
Target Price
$5.00
N/A
AVG Volume (30 Days)
10.8K
18.6K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.59
N/A
Revenue Next Year
$5.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$0.14
52 Week High
$8.55
$12.03

Technical Indicators

Market Signals
Indicator
XBP
TVGN
Relative Strength Index (RSI) 62.22 29.23
Support Level $2.11 $0.30
Resistance Level $3.00 $5.64
Average True Range (ATR) 0.23 0.47
MACD 0.05 -0.14
Stochastic Oscillator 84.77 12.02

Price Performance

Historical Comparison
XBP
TVGN

About XBP XBP Europe Holdings Inc.

XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. The segments of the company are Applied Workflow Automation and Technology. The Applied Workflow Automation segment generates maximum revenue and provides services powered by intelligent, AI-enabled workflows that generate outcomes for client's systems, while the Technology segment focuses on the sale of recurring and perpetual software licenses, software maintenance and professional services, as well as hardware solutions and maintenance.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: